Clinical trial
Sirolimus in Combination With Metronomic Therapy in Children With Recurrent and Refractory Solid Tumors: A Phase I Study
NCT01331135 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sirolimus in Combination With Metronomic Therapy in Children With Recurrent and Refractory Solid Tumors: A Phase I Study
- Lead sponsor
- Emory University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- August 9, 2017
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
astrocytoma, atypical teratoid/rhabdoid tumor, clear cell sarcoma, ependymoma, ewing's sarcoma, germ cell tumor, glioma, hepatoblastoma, medulloblastoma, neuroblastoma, osteosarcoma, renal cell carcinoma, retinoblastoma, rhabdoid tumor, rhabdomyosarcoma, wilms tumor